Liam Ratcliffe

Insider Reports History

Entity
Individual
Location
C/O Access Industries, Inc, 40 West 57 Th St, 28 Th Floor, New York, New York
Signature
/s/ William Cowles, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Liam Ratcliffe:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARVINAS, INC. Director Stock Option (right to buy) 10.2K $163K $16.00 Jun 16, 2022 Direct
Passage BIO, Inc. Director Director Stock Option (Right to Buy) 16.9K May 27, 2021 Direct
Disc Medicine, Inc. Director Stock Option (Right to Buy) 10K Jun 12, 2024 Direct
Eliem Therapeutics, Inc. Director Stock Option (Right To Buy) 10K Jun 26, 2024 Direct

Insider Reports Filed by Liam Ratcliffe

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELYM Eliem Therapeutics, Inc. Jun 26, 2024 1 $0 4 Jun 28, 2024 Director
IRON Disc Medicine, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
IRON Disc Medicine, Inc. Jun 9, 2023 1 $0 4 Jun 9, 2023 Director
ELYM Eliem Therapeutics, Inc. May 18, 2023 1 $0 4 May 22, 2023 Director
IRON Disc Medicine, Inc. Dec 29, 2022 1 $0 4 Jan 3, 2023 Director
IRON Disc Medicine, Inc. Dec 29, 2022 0 $0 3 Jan 3, 2023 Director
ARVN ARVINAS, INC. Jun 16, 2022 1 $0 4 Jun 21, 2022 Director
ELYM Eliem Therapeutics, Inc. May 19, 2022 1 $0 4 Jun 1, 2022 Director
ARVN ARVINAS, INC. Dec 14, 2021 8 -$23.8M 4 Dec 16, 2021 Director
ARVN ARVINAS, INC. Nov 10, 2021 13 -$11.5M 4 Nov 15, 2021 Director
ARVN ARVINAS, INC. Nov 5, 2021 22 -$15.5M 4 Nov 9, 2021 Director
ELYM Eliem Therapeutics, Inc. Aug 9, 2021 1 $0 4 Aug 11, 2021 Director
ELYM Eliem Therapeutics, Inc. Aug 9, 2021 0 $0 3 Aug 9, 2021 Director
ARVN ARVINAS, INC. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director
PASG Passage BIO, Inc. May 27, 2021 1 $0 4 May 28, 2021 Director